HETEROZYGOUS LIPOPROTEIN-LIPASE DEFICIENCY DUE TO A MISSENSE MUTATION AS THE CAUSE OF IMPAIRED TRIGLYCERIDE TOLERANCE WITH MULTIPLE LIPOPROTEIN ABNORMALITIES

被引:139
作者
MIESENBOCK, G
HOLZL, B
FOGER, B
BRANDSTATTER, E
PAULWEBER, B
SANDHOFER, F
PATSCH, JR
机构
[1] UNIV INNSBRUCK, DEPT MED, DIV CLIN ATHEROSCLEROSIS RES, ANICHSTR 35, A-6020 INNSBRUCK, AUSTRIA
[2] LANDESKRANKENANSTALTEN SALZBURG, DEPT MED 1, A-5020 SALZBURG, AUSTRIA
关键词
HIGH-DENSITY LIPOPROTEIN-2; INTERMEDIATE-DENSITY LIPOPROTEIN; LOW-DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; POSTPRANDIAL LIPEMIA;
D O I
10.1172/JCI116222
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In 16 members of two Austrian families affected by a missense mutation at codon 188 of the lipoprotein lipase (LPL) gene (8 heterozygous and 8 normal subjects), carrier status for the mutation as determined by DNA analysis was related to LPL activity in postheparin plasma, to the magnitude of postprandial lipemia, and to concentration, composition, and size of the major lipoprotein classes of postabsorptive plasma. Carriers exhibited clearly reduced LPL activity, normal fasting triglycerides, but pronounced postprandial lipemia. The carriers' impaired triglyceride tolerance, as evident in the postprandial state of challenge only, was associated with a fasting lipoprotein constellation characterized by (a) enrichment of HDL2 with triglycerides, (b) reduced HDL2-cholesterol, (c) enrichment of VLDL and intermediate density lipoprotein (IDL) with cholesteryl esters, (d) elevated IDL levels, and (e) small-sized LDL. Within any given individual, the degrees of expression of these characteristics were quantitatively and continuously related with each other as well as with the magnitude of lipemia and with LPL activity.
引用
收藏
页码:448 / 455
页数:8
相关论文
共 55 条
[51]   DIFFERENT PATTERNS OF POSTPRANDIAL LIPOPROTEIN METABOLISM IN NORMAL, TYPE-IIA, TYPE-III, AND TYPE-IV HYPERLIPOPROTEINEMIC INDIVIDUALS - EFFECTS OF TREATMENT WITH CHOLESTYRAMINE AND GEMFIBROZIL [J].
WEINTRAUB, MS ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (04) :1110-1119
[52]   DIETARY-FAT CLEARANCE IN NORMAL SUBJECTS IS REGULATED BY GENETIC-VARIATION IN APOLIPOPROTEIN-E [J].
WEINTRAUB, MS ;
EISENBERG, S ;
BRESLOW, JL .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (06) :1571-1577
[53]   PHENOTYPIC-EXPRESSION OF HETEROZYGOUS LIPOPROTEIN-LIPASE DEFICIENCY IN THE EXTENDED PEDIGREE OF A PROBAND HOMOZYGOUS FOR A MISSENSE MUTATION [J].
WILSON, DE ;
EMI, M ;
IVERIUS, PH ;
HATA, A ;
WU, LL ;
HILLAS, E ;
WILLIAMS, RR ;
LALOUEL, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (03) :735-750
[54]   HUMAN LIPOPROTEIN-LIPASE COMPLEMENTARY-DNA SEQUENCE [J].
WION, KL ;
KIRCHGESSNER, TG ;
LUSIS, AJ ;
SCHOTZ, MC ;
LAWN, RM .
SCIENCE, 1987, 235 (4796) :1638-1641
[55]  
[No title captured]